Marvin Miller receives $1.9M NIH Grant for TB Research; Marvin Miller receives $1.9M NIH Grant for TB Research. Graduate studies at the University of Notre Dame are driven by the core conviction that Your Research Matters. It often affects the most vulnerable--the sick and the poor in developing countries. Tuberculosis (TB) is a serious global health risk resulting in an estimated 1,800,000 deaths in 2008. Hsiri Therapeutics, LLC: Hsiri Therapeutics is a privately held pharmaceutical company focusing on antibiotics. Find contact's direct phone number, email address, work history, and more. He has spent his entire academic career at Notre Dame, starting as an Assistant Professor in 1977. Marvin Miller - Fighting to Stop Tuberculosis // News // Mike and Josie Harper Cancer Research Institute // University of Notre Dame
View Marvin Miller's business profile as Department of Chemistry and Biochemistry at University of Notre Dame.
The University of Notre Dame’s Advanced Diagnostics & Therapeutics initiative (AD&T) creates technologies and tools to combat disease, promote health, and safeguard the environment. The Company has three development programs all licensed in from the laboratories of Dr. Marvin Miller at the University of Notre Dame.
Our students pursue research in a variety of degree programs renowned for … The primary interests in Professor Miller's laboratory are in synthetic and bioorganic chemistry. Hsiri Therapeutics, LLC Hsiri is a start-up antibiotics company founded by two seasoned pharma executives with novel antibiotics from Dr. Marvin Miller at the University of Notre Dame. ... Marvin Miller. He served as chair of the department from 2002-2005. Chemistry Tree: mentors, trainees, research areas and affiliations for Marvin Miller, Chemistry, University of Notre Dame Tuberculosis research at Notre Dame. Tuberculosis is a widespread infectious disease that has infected one-third of the world's population. Overview.
Marvin Miller, the George and Winifred Clark Chair in Chemistry, and Michael Ferdig, associate professor of biological sciences at the University of Notre Dame, are co-authors of a study recently published in the Journal of the American Chemical Society on a potential breakthrough in the fight against tuberculosis and malaria—global diseases that each kill some 2 million people a year. The Mike and Josie Harper Cancer Research Institute is dedicated to conducting innovative and integrative research that confronts the complex challenges of cancer. Hsiri Therapeutics. Published: June 16, 2010.